capecitabine has been researched along with Neoplasms, Sweat Gland in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budi, NYP; Fauzi, AR; Handaya, AY; Nugroho, GMA | 1 |
Beckford, A; Demierre, MF; Goldberg, L; Jalisi, S; Lerner, A; Ugent, S | 1 |
Delaunay, M; Jouary, T; Kaiafa, A; Lepreux, S; Lipinski, P; Taïeb, A; Vergier, B | 1 |
3 other study(ies) available for capecitabine and Neoplasms, Sweat Gland
Article | Year |
---|---|
Wide excision and reconstruction surgery for recurrent sweat gland umbilical adenocarcinoma followed by chemotherapy can prevent the risk of recurrences.
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Biopsy, Fine-Needle; Capecitabine; Female; Humans; Neoplasm Recurrence, Local; Plastic Surgery Procedures; Risk; Sweat Gland Neoplasms; Umbilicus | 2018 |
Complete response of metastatic malignant hidradenocarcinoma to capecitabine treatment.
Topics: Acrospiroma; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Fluorouracil; Humans; Male; Remission Induction; Scalp; Sweat Gland Neoplasms | 2011 |
Metastatic hidradenocarcinoma: efficacy of capecitabine.
Topics: Adenoma, Sweat Gland; Antimetabolites, Antineoplastic; Axilla; Capecitabine; Deoxycytidine; Diagnosis, Differential; Drug Administration Schedule; Elbow; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Sweat Gland Neoplasms | 2006 |